Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C59H88N2O20 |
| Molecular Weight | 1145.3314 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 21 / 21 |
| E/Z Centers | 7 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC[C@H](C(=O)NC\C=C\C=C(/C)[C@@H](OC)[C@@H](C)[C@@H]1O[C@H](\C=C\C=C\C=C(/C)C(=O)C2=C(O)C=CN(C)C2=O)[C@H](O)[C@@H]1O)[C@@]3(O)O[C@@H](\C=C\C=C/C)C(C)(C)[C@@H](O[C@@H]4O[C@H](C)[C@@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](O)[C@H]5OC)[C@@H](OC)[C@H]4O)[C@H]3O
InChI
InChIKey=ASOJLQIBBYOFDE-SBHXXGSWSA-N
InChI=1S/C59H88N2O20/c1-15-17-19-27-39-58(8,9)53(80-56-45(67)50(74-13)49(35(7)76-56)79-57-51(75-14)44(66)48(73-12)34(6)77-57)52(68)59(71,81-39)36(16-2)54(69)60-29-23-22-25-32(4)46(72-11)33(5)47-43(65)42(64)38(78-47)26-21-18-20-24-31(3)41(63)40-37(62)28-30-61(10)55(40)70/h15,17-28,30,33-36,38-39,42-53,56-57,62,64-68,71H,16,29H2,1-14H3,(H,60,69)/b17-15-,20-18+,23-22+,26-21+,27-19+,31-24+,32-25+/t33-,34+,35-,36-,38-,39+,42+,43+,44-,45-,46-,47+,48+,49-,50+,51-,52-,53+,56+,57+,59-/m1/s1
| Molecular Formula | C59H88N2O20 |
| Molecular Weight | 1145.3314 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 21 / 21 |
| E/Z Centers | 7 |
| Optical Activity | UNSPECIFIED |
Efrotomycin (ET) is an antibiotic obtained by the incubation of Nocardia lacamduranns, and
composed of 4 components: Efrotomycin A1, Efrotomycin A2, Efrotomycin B1, and Efrotomycin B2. Although its antibacterial spectrum is narrow, ET has an antibacterial effect on part of the Grampositive
bacteria and on treponema, and has a growth promoting effect on pigs etc. ET is a pure-grade antibiotic that was designated as a feed additive. Under the brand name Producil Efrotomycin was indicated for increased rate of weight gain when incorporated into complete swine feeds at 3.6 to 14.5 g/ton. This antibiotic is a potent inhibitor of bacterial protein synthesis by interfering
with peptide transfer reactions associated with the elongation factor Tu.
Originator
Sources: http://www.trademarkia.com/producil-73528908.html | http://pubs.acs.org/doi/pdf/10.1021/ja00292a038
Curator's Comment: # MERCK
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: P0CE47 Gene ID: 947838.0 Gene Symbol: tufA Target Organism: Escherichia coli (strain K12) |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Producil Approved UseFor increased rate of weight gain when incorporated into complete swine feeds at 3.6 to 14.5 g/ton. Feed Efficiency:
For improved feed efficiency when incorporated into complete swine feeds at 3.6 g/ton. Launch Date1992 |
Sample Use Guides
Pigs: Dosage:
Form: A free-flowing, non-dusty, granular premix containing 32 grams of efrotomycin activity per kilogram intended for incorporation in swine rations.
Route of administration: Orally as an additive to swine feeds.
Recommended dosage: The effective range for efrotomycin use in swine is 4 to 16 ppm (3.6 to 14.5 g/ton) inclusive for increases in average daily gain and 4 ppm (3.6 g/ton) for improvements in feed efficiency. Blend Producil into complete swine feeds at 4 oz - 16 oz per ton to supply 3.6 g - 14.5 g efrotomycin per ton of feed.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3802745
Efrotomycin (MIC50 = 0.125, MIC90 = 0.25 ug/ml) was highly active against C. difficile.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:22:53 GMT 2025
by
admin
on
Mon Mar 31 18:22:53 GMT 2025
|
| Record UNII |
5BPJ82Q45X
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CFR |
21 CFR 558.235
Created by
admin on Mon Mar 31 18:22:53 GMT 2025 , Edited by admin on Mon Mar 31 18:22:53 GMT 2025
|
||
|
NCI_THESAURUS |
C258
Created by
admin on Mon Mar 31 18:22:53 GMT 2025 , Edited by admin on Mon Mar 31 18:22:53 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C83686
Created by
admin on Mon Mar 31 18:22:53 GMT 2025 , Edited by admin on Mon Mar 31 18:22:53 GMT 2025
|
PRIMARY | |||
|
56592-32-6
Created by
admin on Mon Mar 31 18:22:53 GMT 2025 , Edited by admin on Mon Mar 31 18:22:53 GMT 2025
|
PRIMARY | |||
|
W-69
Created by
admin on Mon Mar 31 18:22:53 GMT 2025 , Edited by admin on Mon Mar 31 18:22:53 GMT 2025
|
PRIMARY | |||
|
135564847
Created by
admin on Mon Mar 31 18:22:53 GMT 2025 , Edited by admin on Mon Mar 31 18:22:53 GMT 2025
|
PRIMARY | |||
|
CHEMBL2106443
Created by
admin on Mon Mar 31 18:22:53 GMT 2025 , Edited by admin on Mon Mar 31 18:22:53 GMT 2025
|
PRIMARY | |||
|
SUB06472MIG
Created by
admin on Mon Mar 31 18:22:53 GMT 2025 , Edited by admin on Mon Mar 31 18:22:53 GMT 2025
|
PRIMARY | |||
|
5BPJ82Q45X
Created by
admin on Mon Mar 31 18:22:53 GMT 2025 , Edited by admin on Mon Mar 31 18:22:53 GMT 2025
|
PRIMARY | |||
|
C012954
Created by
admin on Mon Mar 31 18:22:53 GMT 2025 , Edited by admin on Mon Mar 31 18:22:53 GMT 2025
|
PRIMARY | |||
|
DB11401
Created by
admin on Mon Mar 31 18:22:53 GMT 2025 , Edited by admin on Mon Mar 31 18:22:53 GMT 2025
|
PRIMARY | |||
|
m4842
Created by
admin on Mon Mar 31 18:22:53 GMT 2025 , Edited by admin on Mon Mar 31 18:22:53 GMT 2025
|
PRIMARY | Merck Index | ||
|
5687
Created by
admin on Mon Mar 31 18:22:53 GMT 2025 , Edited by admin on Mon Mar 31 18:22:53 GMT 2025
|
PRIMARY | |||
|
DTXSID501318259
Created by
admin on Mon Mar 31 18:22:53 GMT 2025 , Edited by admin on Mon Mar 31 18:22:53 GMT 2025
|
PRIMARY | |||
|
100000080537
Created by
admin on Mon Mar 31 18:22:53 GMT 2025 , Edited by admin on Mon Mar 31 18:22:53 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |